{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:58:29Z","timestamp":1793206709267,"version":"4.5.0"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["81072398"],"award-info":[{"award-number":["81072398"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00415-025-13594-z","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:58:04Z","timestamp":1769698684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunological mechanisms and therapeutic advances in diabetic neuropathy"],"prefix":"10.1007","volume":"273","author":[{"given":"Suli","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-7364","authenticated-orcid":false,"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"13594_CR1","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S et al (2022) IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119","journal-title":"Diabetes Res Clin Pract"},{"key":"13594_CR2","unstructured":"(2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England) 402(10397):203\u2013234"},{"issue":"7","key":"13594_CR3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41574-021-00496-z","volume":"17","author":"G Sloan","year":"2021","unstructured":"Sloan G, Selvarajah D, Tesfaye S (2021) Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol 17(7):400\u2013420","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"13594_CR4","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/dc13-0012","volume":"36","author":"R Pop-Busui","year":"2013","unstructured":"Pop-Busui R, Lu J, Brooks MM et al (2013) Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care 36(10):3208\u20133215","journal-title":"Diabetes Care"},{"issue":"1","key":"13594_CR5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R et al (2019) Diabetic neuropathy. Nat Rev Dis Primers 5(1):42","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"13594_CR6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan BC, Cheng HT, Stables CL et al (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 11(6):521\u2013534","journal-title":"Lancet Neurol"},{"issue":"Suppl 2","key":"13594_CR7","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.2337\/diab.46.2.S54","volume":"46","author":"PK Thomas","year":"1997","unstructured":"Thomas PK (1997) Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 46(Suppl 2):S54-57","journal-title":"Diabetes"},{"issue":"10","key":"13594_CR8","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc11-1108","volume":"34","author":"CA Abbott","year":"2011","unstructured":"Abbott CA, Malik RA, Van Ross ER et al (2011) Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 34(10):2220\u20132224","journal-title":"Diabetes Care"},{"key":"13594_CR9","volume":"222","author":"Y Tao","year":"2025","unstructured":"Tao Y, Zhang HY, Macgilchrist C et al (2025) Prevalence and risk factors of painful diabetic neuropathy: a systematic review and meta-analysis. Diabetes Res Clin Pract 222:112099","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"13594_CR10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1526-4637.2007.00347.x","volume":"9","author":"A Veves","year":"2008","unstructured":"Veves A, Backonja M, Malik RA (2008) Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med 9(6):660\u2013674","journal-title":"Pain Med"},{"key":"13594_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11030230","author":"M Sempere-Bigorra","year":"2021","unstructured":"Sempere-Bigorra M, Juli\u00e1n-Rochina I, Cauli O (2021) Differences and similarities in neuropathy in type 1 and 2 diabetes: a systematic review. J Pers Med. https:\/\/doi.org\/10.3390\/jpm11030230","journal-title":"J Pers Med"},{"issue":"5","key":"13594_CR12","volume":"2","author":"JME Jende","year":"2019","unstructured":"Jende JME, Groener JB, Rother C et al (2019) Association of serum cholesterol levels with peripheral nerve damage in patients with type 2 diabetes. JAMA Netw Open 2(5):e194798","journal-title":"JAMA Netw Open"},{"issue":"3","key":"13594_CR13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.25182","volume":"83","author":"JME Jende","year":"2018","unstructured":"Jende JME, Groener JB, Oikonomou D et al (2018) Diabetic neuropathy differs between type 1 and type 2 diabetes: insights from magnetic resonance neurography. Ann Neurol 83(3):588\u2013598","journal-title":"Ann Neurol"},{"issue":"6","key":"13594_CR14","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/brain\/awab079","volume":"144","author":"TS Jensen","year":"2021","unstructured":"Jensen TS, Karlsson P, Gylfadottir SS et al (2021) Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain 144(6):1632\u20131645","journal-title":"Brain"},{"key":"13594_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154867","volume":"123","author":"S Cernea","year":"2021","unstructured":"Cernea S, Raz I (2021) Management of diabetic neuropathy. Metabolism 123:154867","journal-title":"Metabolism"},{"key":"13594_CR16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3389\/fnins.2018.01038","volume":"12","author":"M Richner","year":"2018","unstructured":"Richner M, Ferreira N, Dudele A et al (2018) Functional and structural changes of the blood-nerve-barrier in diabetic neuropathy. Front Neurosci 12:1038","journal-title":"Front Neurosci"},{"issue":"12","key":"13594_CR17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/jnnp-2021-328489","volume":"94","author":"M Silsby","year":"2023","unstructured":"Silsby M, Feldman EL, Dortch RD et al (2023) Advances in diagnosis and management of distal sensory polyneuropathies. J Neurol Neurosurg Psychiatry 94(12):1025\u20131039","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"20","key":"13594_CR18","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1001\/jama.2015.13611","volume":"314","author":"BC Callaghan","year":"2015","unstructured":"Callaghan BC, Price RS, Feldman EL (2015) Distal symmetric polyneuropathy: a review. JAMA 314(20):2172\u20132181","journal-title":"JAMA"},{"issue":"1","key":"13594_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R et al (2019) Diabetic neuropathy. Nat Rev Dis Primers 5(1):41","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"13594_CR20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1054\/jpai.2001.21592","volume":"2","author":"KO Aley","year":"2001","unstructured":"Aley KO, Levine JD (2001) Rapid onset pain induced by intravenous streptozotocin in the rat. J Pain 2(3):146\u2013150","journal-title":"J Pain"},{"issue":"1-2","key":"13594_CR21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-3959(98)00239-5","volume":"80","author":"MJ Field","year":"1999","unstructured":"Field MJ, Mccleary S, Hughes J et al (1999) Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 80(1\u20132):391\u2013398","journal-title":"Pain"},{"issue":"2","key":"13594_CR22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4093\/dmj.2021.0347","volume":"46","author":"MJ Hossain","year":"2022","unstructured":"Hossain MJ, Kendig MD, Letton ME et al (2022) Peripheral neuropathy phenotyping in rat models of type 2 diabetes mellitus: evaluating uptake of the Neurodiab guidelines and identifying future directions. Diabetes Metab J 46(2):198\u2013221","journal-title":"Diabetes Metab J"},{"key":"13594_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9060608","author":"L Ciarlo","year":"2021","unstructured":"Ciarlo L, Marzoli F, Minosi P et al (2021) Ammonium glycyrrhizinate prevents apoptosis and mitochondrial dysfunction induced by high glucose in SH-SY5Y cell line and counteracts neuropathic pain in streptozotocin-induced diabetic mice. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9060608","journal-title":"Biomedicines"},{"issue":"10","key":"13594_CR24","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1517\/17460440903266829","volume":"4","author":"G Melli","year":"2009","unstructured":"Melli G, H\u00f6ke A (2009) Dorsal root ganglia sensory neuronal cultures: a tool for drug discovery for peripheral neuropathies. Expert Opin Drug Discov 4(10):1035\u20131045","journal-title":"Expert Opin Drug Discov"},{"key":"13594_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells9091948","author":"YC Cheng","year":"2020","unstructured":"Cheng YC, Chu LW, Chen JY et al (2020) Loganin attenuates high glucose-induced Schwann cells pyroptosis by inhibiting ROS generation and NLRP3 inflammasome activation. Cells. https:\/\/doi.org\/10.3390\/cells9091948","journal-title":"Cells"},{"issue":"5","key":"13594_CR26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.stem.2023.04.006","volume":"30","author":"H Majd","year":"2023","unstructured":"Majd H, Amin S, Ghazizadeh Z et al (2023) Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy. Cell Stem Cell 30(5):632-647.e610","journal-title":"Cell Stem Cell"},{"issue":"6","key":"13594_CR27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"A Goldin","year":"2006","unstructured":"Goldin A, Beckman JA, Schmidt AM et al (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114(6):597\u2013605","journal-title":"Circulation"},{"issue":"2","key":"13594_CR28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0006-8993(02)04149-5","volume":"966","author":"L Ma","year":"2003","unstructured":"Ma L, Carter RJ, Morton AJ et al (2003) RAGE is expressed in pyramidal cells of the hippocampus following moderate hypoxic-ischemic brain injury in rats. Brain Res 966(2):167\u2013174","journal-title":"Brain Res"},{"issue":"1","key":"13594_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2001.7732","volume":"171","author":"LF Lue","year":"2001","unstructured":"Lue LF, Walker DG, Brachova L et al (2001) Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer\u2019s disease: identification of a cellular activation mechanism. Exp Neurol 171(1):29\u201345","journal-title":"Exp Neurol"},{"issue":"6","key":"13594_CR30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mus.20039","volume":"29","author":"KM Haslbeck","year":"2004","unstructured":"Haslbeck KM, Bierhaus A, Erwin S et al (2004) Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy. Muscle Nerve 29(6):853\u2013860","journal-title":"Muscle Nerve"},{"issue":"15","key":"13594_CR31","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1096\/fj.04-1900com","volume":"18","author":"LL Rong","year":"2004","unstructured":"Rong LL, Yan SF, Wendt T et al (2004) RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. FASEB J 18(15):1818\u20131825","journal-title":"FASEB J"},{"issue":"2","key":"13594_CR32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2006-0073","volume":"148","author":"AM Vincent","year":"2007","unstructured":"Vincent AM, Perrone L, Sullivan KA et al (2007) Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148(2):548\u2013558","journal-title":"Endocrinology"},{"key":"13594_CR33","volume":"12","author":"H Lin","year":"2025","unstructured":"Lin H, Yang Y, Wang X et al (2025) Targeting the AGEs-RAGE axis: pathogenic mechanisms and therapeutic interventions in diabetic wound healing. Front Med 12:1667620","journal-title":"Front Med"},{"issue":"2","key":"13594_CR34","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s12035-017-0419-4","volume":"55","author":"K G\u0105siorowski","year":"2018","unstructured":"G\u0105siorowski K, Brokos B, Echeverria V et al (2018) RAGE-TLR crosstalk sustains chronic inflammation in neurodegeneration. Mol Neurobiol 55(2):1463\u20131476","journal-title":"Mol Neurobiol"},{"issue":"3","key":"13594_CR35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2337\/db19-0517","volume":"69","author":"SA Eid","year":"2020","unstructured":"Eid SA, El Massry M, Hichor M et al (2020) Targeting the NADPH oxidase-4 and liver X receptor pathway preserves Schwann cell integrity in diabetic mice. Diabetes 69(3):448\u2013464","journal-title":"Diabetes"},{"issue":"4","key":"13594_CR36","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/cns.14060","volume":"29","author":"D Zhang","year":"2023","unstructured":"Zhang D, Jing B, Chen ZN et al (2023) Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4\/NF-\u03baB pathway. CNS Neurosci Ther 29(4):1000\u20131011","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"13594_CR37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7150\/ijbs.63219","volume":"18","author":"L Wan","year":"2022","unstructured":"Wan L, Bai X, Zhou Q et al (2022) The advanced glycation end-products (AGEs)\/ROS\/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration. Int J Biol Sci 18(2):809\u2013825","journal-title":"Int J Biol Sci"},{"issue":"3","key":"13594_CR38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10522-019-09808-3","volume":"20","author":"T Teissier","year":"2019","unstructured":"Teissier T, Boulanger \u00c9 (2019) The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging. Biogerontology 20(3):279\u2013301","journal-title":"Biogerontology"},{"issue":"12","key":"13594_CR39","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, N\u00fa\u00f1ez G (2016) Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci 41(12):1012\u20131021","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"13594_CR40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/138945008783431718","volume":"9","author":"NE Cameron","year":"2008","unstructured":"Cameron NE, Cotter MA (2008) Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Targets 9(1):60\u201367","journal-title":"Curr Drug Targets"},{"issue":"6","key":"13594_CR41","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.euroneuro.2015.03.006","volume":"25","author":"M Moretti","year":"2015","unstructured":"Moretti M, Budni J, Freitas AE et al (2015) TNF-\u03b1-induced depressive-like phenotype and p38(MAPK) activation are abolished by ascorbic acid treatment. Eur Neuropsychopharmacol 25(6):902\u2013912","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"13594_CR42","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.2337\/db07-0740","volume":"56","author":"AP Kellogg","year":"2007","unstructured":"Kellogg AP, Wiggin TD, Larkin DD et al (2007) Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 56(12):2997\u20133005","journal-title":"Diabetes"},{"issue":"1","key":"13594_CR43","volume":"12","author":"WF Vieira","year":"2022","unstructured":"Vieira WF, Malange KF, De Magalh\u00e3es SF et al (2022) Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation. Sci Rep 12(1):16730","journal-title":"Sci Rep"},{"issue":"12","key":"13594_CR44","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/01.RES.0000103862.26506.3D","volume":"93","author":"SF Yan","year":"2003","unstructured":"Yan SF, Ramasamy R, Naka Y et al (2003) Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93(12):1159\u20131169","journal-title":"Circ Res"},{"issue":"7","key":"13594_CR45","volume":"31","author":"Z Hu","year":"2020","unstructured":"Hu Z, Deng N, Liu K et al (2020) CNTF-STAT3-IL-6 axis mediates neuroinflammatory cascade across Schwann cell-neuron-microglia. Cell Rep 31(7):107657","journal-title":"Cell Rep"},{"key":"13594_CR46","volume":"874","author":"NME Abo El-Nasr","year":"2020","unstructured":"Abo El-Nasr NME, Saleh DO, Mahmoud SS et al (2020) Olmesartan attenuates type 2 diabetes-associated liver injury: cross-talk of AGE\/RAGE\/JNK, STAT3\/SCOS3 and RAS signaling pathways. Eur J Pharmacol 874:173010","journal-title":"Eur J Pharmacol"},{"key":"13594_CR47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.expneurol.2017.11.012","volume":"300","author":"CP Ding","year":"2018","unstructured":"Ding CP, Guo YJ, Li HN et al (2018) Red nucleus interleukin-6 participates in the maintenance of neuropathic pain through JAK\/STAT3 and ERK signaling pathways. Exp Neurol 300:212\u2013221","journal-title":"Exp Neurol"},{"key":"13594_CR48","volume":"333","author":"S Wang","year":"2024","unstructured":"Wang S, Taledaohan A, Tuohan M et al (2024) Jinmaitong alleviates diabetic neuropathic pain by inhibiting JAK2\/STAT3 signaling in microglia of diabetic rats. J Ethnopharmacol 333:118442","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"13594_CR49","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.cellsig.2011.03.019","volume":"23","author":"S Liu","year":"2011","unstructured":"Liu S, Yuan Q, Zhao S et al (2011) High glucose induces apoptosis in embryonic neural progenitor cells by a pathway involving protein PKC\u03b4. Cell Signal 23(8):1366\u20131374","journal-title":"Cell Signal"},{"key":"13594_CR50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.redox.2018.09.025","volume":"20","author":"T Yuan","year":"2019","unstructured":"Yuan T, Yang T, Chen H et al (2019) New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol 20:247\u2013260","journal-title":"Redox Biol"},{"issue":"7","key":"13594_CR51","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.freeradbiomed.2004.12.002","volume":"38","author":"M Nitti","year":"2005","unstructured":"Nitti M, D\u2019abramo C, Traverso N et al (2005) Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons. Free Radic Biol Med 38(7):846\u2013856","journal-title":"Free Radic Biol Med"},{"issue":"37","key":"13594_CR52","doi-asserted-by":"crossref","first-page":"32107","DOI":"10.1074\/jbc.M504432200","volume":"280","author":"AE Santiago-Walker","year":"2005","unstructured":"Santiago-Walker AE, Fikaris AJ, Kao GD et al (2005) Protein kinase C delta stimulates apoptosis by initiating G1 phase cell cycle progression and S phase arrest. J Biol Chem 280(37):32107\u201332114","journal-title":"J Biol Chem"},{"issue":"44","key":"13594_CR53","doi-asserted-by":"crossref","first-page":"45603","DOI":"10.1074\/jbc.M407448200","volume":"279","author":"TA Devries","year":"2004","unstructured":"Devries TA, Kalkofen RL, Matassa AA et al (2004) Protein kinase Cdelta regulates apoptosis via activation of STAT1. J Biol Chem 279(44):45603\u201345612","journal-title":"J Biol Chem"},{"issue":"3","key":"13594_CR54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/15287399409531883","volume":"42","author":"EJ Lehning","year":"1994","unstructured":"Lehning EJ, Lopachin RM, Mathew J et al (1994) Changes in Na-K ATPase and protein kinase C activities in peripheral nerve of acrylamide-treated rats. J Toxicol Environ Health 42(3):331\u2013342","journal-title":"J Toxicol Environ Health"},{"key":"13594_CR55","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160555","author":"S Osonoi","year":"2022","unstructured":"Osonoi S, Mizukami H, Takeuchi Y et al (2022) RAGE activation in macrophages and development of experimental diabetic polyneuropathy. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.160555","journal-title":"JCI Insight"},{"key":"13594_CR56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173874","volume":"894","author":"H Jahan","year":"2021","unstructured":"Jahan H, Choudhary MI (2021) Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE\/TLR4-reactive oxygen species-activated NF-k\u03b2 nexus. Eur J Pharmacol 894:173874","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"13594_CR57","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/db12-0632","volume":"62","author":"JK Juranek","year":"2013","unstructured":"Juranek JK, Geddis MS, Song F et al (2013) RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice. Diabetes 62(3):931\u2013943","journal-title":"Diabetes"},{"issue":"5","key":"13594_CR58","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajpath.2024.01.007","volume":"194","author":"T Abuduyimiti","year":"2024","unstructured":"Abuduyimiti T, Goto H, Kimura K et al (2024) Diabetes accelerates steatohepatitis in mice: liver pathology and single-cell gene expression signatures. Am J Pathol 194(5):693\u2013707","journal-title":"Am J Pathol"},{"key":"13594_CR59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2017.02.010","volume":"305","author":"J Chen","year":"2017","unstructured":"Chen J, Sun Z, Jin M et al (2017) Inhibition of AGEs\/RAGE\/Rho\/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1\/M2 polarization through the NF-\u03baB pathway. J Neuroimmunol 305:108\u2013114","journal-title":"J Neuroimmunol"},{"issue":"3","key":"13594_CR60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0022-510X(77)90132-0","volume":"33","author":"DR Smith","year":"1977","unstructured":"Smith DR, Kobrine AI, Rizzoli HV (1977) Absence of autoregulation in peripheral nerve blood flow. J Neurol Sci 33(3):347\u2013352","journal-title":"J Neurol Sci"},{"issue":"4","key":"13594_CR61","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00125-014-3461-z","volume":"58","author":"L \u00d8stergaard","year":"2015","unstructured":"\u00d8stergaard L, Finnerup NB, Terkelsen AJ et al (2015) The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy. Diabetologia 58(4):666\u2013677","journal-title":"Diabetologia"},{"key":"13594_CR62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/B978-0-444-53480-4.00023-0","volume":"126","author":"H Nukada","year":"2014","unstructured":"Nukada H (2014) Ischemia and diabetic neuropathy. Handb Clin Neurol 126:469\u2013487","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"13594_CR63","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410370412","volume":"37","author":"C Giannini","year":"1995","unstructured":"Giannini C, Dyck PJ (1995) Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 37(4):498\u2013504","journal-title":"Ann Neurol"},{"key":"13594_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11050900","author":"K Kostov","year":"2021","unstructured":"Kostov K, Blazhev A (2021) Serum anti-collagen IV IgM and IgG antibodies as indicators of low vascular turnover of collagen IV in patients with long-term complications of type 2 diabetes. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics11050900","journal-title":"Diagnostics"},{"issue":"9","key":"13594_CR65","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1160\/TH17-04-0259","volume":"117","author":"M Konieczy\u0144ska","year":"2017","unstructured":"Konieczy\u0144ska M, Bryk AH, Malinowski KP et al (2017) Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes. Thromb Haemost 117(9):1671\u20131678","journal-title":"Thromb Haemost"},{"issue":"4","key":"13594_CR66","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-5491.1992.tb01798.x","volume":"9","author":"Y Hayashi","year":"1992","unstructured":"Hayashi Y, Makino H, Ota Z (1992) Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes. Diabet Med 9(4):366\u2013370","journal-title":"Diabet Med"},{"key":"13594_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126396","author":"NA Mohd Nor","year":"2022","unstructured":"Mohd Nor NA, Budin SB, Zainalabidin S et al (2022) The role of polyphenol in modulating associated genes in diabetes-induced vascular disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23126396","journal-title":"Int J Mol Sci"},{"issue":"9","key":"13594_CR68","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107(9):1058\u20131070","journal-title":"Circ Res"},{"issue":"6865","key":"13594_CR69","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813\u2013820","journal-title":"Nature"},{"issue":"4","key":"13594_CR70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/EDR.2003.271","volume":"4","author":"G Pittenger","year":"2003","unstructured":"Pittenger G, Vinik A (2003) Nerve growth factor and diabetic neuropathy. J Diabetes Res 4(4):271\u2013285","journal-title":"J Diabetes Res"},{"key":"13594_CR71","volume":"229","author":"JW Park","year":"2020","unstructured":"Park JW, Okamoto LE, Shibao CA et al (2020) Pharmacologic treatment of orthostatic hypotension. Auton Neurosci 229:102721","journal-title":"Auton Neurosci"},{"issue":"5","key":"13594_CR72","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1210\/er.2018-00161","volume":"40","author":"AE Bharucha","year":"2019","unstructured":"Bharucha AE, Kudva YC, Prichard DO (2019) Diabetic gastroparesis. Endocr Rev 40(5):1318\u20131352","journal-title":"Endocr Rev"},{"key":"13594_CR73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-med-043021-033114","volume":"75","author":"BR Dillon","year":"2024","unstructured":"Dillon BR, Ang L, Pop-Busui R (2024) Spectrum of diabetic neuropathy: new insights in diagnosis and treatment. Annu Rev Med 75:293\u2013306","journal-title":"Annu Rev Med"},{"issue":"2","key":"13594_CR74","doi-asserted-by":"crossref","first-page":"H549","DOI":"10.1152\/ajpheart.00726.2020","volume":"320","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang H, Wang S et al (2021) Reduced pericyte and tight junction coverage in old diabetic rats are associated with hyperglycemia-induced cerebrovascular pericyte dysfunction. Am J Physiol Heart Circ Physiol 320(2):H549-h562","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"13594_CR75","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00125-004-1523-3","volume":"47","author":"AW Stitt","year":"2004","unstructured":"Stitt AW, Hughes SJ, Canning P et al (2004) Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia 47(10):1735\u20131746","journal-title":"Diabetologia"},{"issue":"1","key":"13594_CR76","volume":"29","author":"TF Shi","year":"2024","unstructured":"Shi TF, Zhou Z, Jiang WJ et al (2024) Hyperglycemia-induced oxidative stress exacerbates mitochondrial apoptosis damage to cochlear stria vascularis pericytes via the ROS-mediated Bcl-2\/CytC\/AIF pathway. Redox Rep 29(1):2382943","journal-title":"Redox Rep"},{"issue":"9","key":"13594_CR77","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2337\/db08-0325","volume":"57","author":"F Pfister","year":"2008","unstructured":"Pfister F, Feng Y, Vom Hagen F et al (2008) Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 57(9):2495\u20132502","journal-title":"Diabetes"},{"issue":"26","key":"13594_CR78","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.2174\/09298673113209990022","volume":"20","author":"E Beltramo","year":"2013","unstructured":"Beltramo E, Porta M (2013) Pericyte loss in diabetic retinopathy: mechanisms and consequences. Curr Med Chem 20(26):3218\u20133225","journal-title":"Curr Med Chem"},{"issue":"7806","key":"13594_CR79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP et al (2020) APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline. Nature 581(7806):71\u201376","journal-title":"Nature"},{"issue":"7","key":"13594_CR80","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41593-019-0434-z","volume":"22","author":"AM Nikolakopoulou","year":"2019","unstructured":"Nikolakopoulou AM, Montagne A, Kisler K et al (2019) Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss. Nat Neurosci 22(7):1089\u20131098","journal-title":"Nat Neurosci"},{"issue":"s2","key":"13594_CR81","first-page":"S281","volume":"99","author":"D Nelson","year":"2024","unstructured":"Nelson D, Thompson KJ, Wang L et al (2024) Pericyte control of gene expression in the blood\u2013brain barrier endothelium: implications for Alzheimer\u2019s disease. J Alzheimer\u2019s Dis JAD 99(s2):S281-s297","journal-title":"J Alzheimer\u2019s Dis JAD"},{"key":"13594_CR82","first-page":"589","volume-title":"Jasper\u2019s basic mechanisms of the epilepsies","author":"N Marchi","year":"2024","unstructured":"Marchi N, Brewster AL (2024) Pericytes and microglia: neurovascular and immune regulatory cells in seizure disorders. In: Noebels JL, Avoli M, Rogawski MA et al (eds) Jasper\u2019s basic mechanisms of the epilepsies. Oxford University Press, New York, pp 589\u2013610"},{"issue":"8","key":"13594_CR83","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1538-7836.2004.00835.x","volume":"2","author":"L Piconi","year":"2004","unstructured":"Piconi L, Quagliaro L, Da Ros R et al (2004) Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost JTH 2(8):1453\u20131459","journal-title":"J Thromb Haemost JTH"},{"issue":"6","key":"13594_CR84","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0891-5849(03)00401-5","volume":"35","author":"F Pricci","year":"2003","unstructured":"Pricci F, Leto G, Amadio L et al (2003) Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. Free Radic Biol Med 35(6):683\u2013694","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"13594_CR85","first-page":"41","volume":"65","author":"RR Myers","year":"1991","unstructured":"Myers RR, Heckman HM, Galbraith JA et al (1991) Subperineurial demyelination associated with reduced nerve blood flow and oxygen tension after epineurial vascular stripping. Lab Investig J Tech Methods Pathol 65(1):41\u201350","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"13594_CR86","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114821","volume":"378","author":"Y Feng","year":"2024","unstructured":"Feng Y, Huang Z, Ma X et al (2024) Intermittent theta-burst stimulation alleviates hypoxia-ischemia-caused myelin damage and neurologic disability. Exp Neurol 378:114821","journal-title":"Exp Neurol"},{"key":"13594_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010062","author":"Y Takeshita","year":"2020","unstructured":"Takeshita Y, Sato R, Kanda T (2020) Blood-nerve barrier (BNB) pathology in diabetic peripheral neuropathy and in vitro human BNB model. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22010062","journal-title":"Int J Mol Sci"},{"key":"13594_CR88","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155539","volume":"143","author":"F Khodakhah","year":"2021","unstructured":"Khodakhah F, Tahamtan A, Marzban M et al (2021) Hyperglycemia results in decreased immune cell infiltration and increased viral load in the lung in a mouse model of RSV infection. Cytokine 143:155539","journal-title":"Cytokine"},{"issue":"4","key":"13594_CR89","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s13340-024-00741-6","volume":"15","author":"H Lee","year":"2024","unstructured":"Lee H, Kim MJ, Lee IK et al (2024) Impact of hyperglycemia on immune cell function: a comprehensive review. Diabetol Int 15(4):745\u2013760","journal-title":"Diabetol Int"},{"issue":"2","key":"13594_CR90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","volume":"351","author":"N Jafar","year":"2016","unstructured":"Jafar N, Edriss H, Nugent K (2016) The effect of short-term hyperglycemia on the innate immune system. Am J Med Sci 351(2):201\u2013211","journal-title":"Am J Med Sci"},{"issue":"8","key":"13594_CR91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022865","volume":"6","author":"ML Lamers","year":"2011","unstructured":"Lamers ML, Almeida ME, Vicente-Manzanares M et al (2011) High glucose-mediated oxidative stress impairs cell migration. PLoS ONE 6(8):e22865","journal-title":"PLoS ONE"},{"key":"13594_CR92","volume":"264","author":"H Liu","year":"2021","unstructured":"Liu H, Bian W, Yang D et al (2021) Inhibiting the Piezo1 channel protects microglia from acute hyperglycaemia damage through the JNK1 and mTOR signalling pathways. Life Sci 264:118667","journal-title":"Life Sci"},{"key":"13594_CR93","volume":"6","author":"YS Lee","year":"2016","unstructured":"Lee YS, Eun HS, Kim SY et al (2016) Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice. Sci Rep 6:30656","journal-title":"Sci Rep"},{"key":"13594_CR94","volume":"10","author":"A Farhan","year":"2023","unstructured":"Farhan A, Hassan G, Ali SHL et al (2023) Spontaneous NETosis in diabetes: a role of hyperglycemia mediated ROS and autophagy. Front Med Lausanne 10:1076690","journal-title":"Front Med Lausanne"},{"issue":"1","key":"13594_CR95","volume":"15","author":"W Li","year":"2025","unstructured":"Li W, Xu G, Chai GW et al (2025) The MiR-139-5p and CXCR4 axis may play a role in high glucose-induced inflammation by regulating monocyte migration. Sci Rep 15(1):6738","journal-title":"Sci Rep"},{"issue":"12","key":"13594_CR96","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.cmet.2024.10.004","volume":"36","author":"V Gray","year":"2024","unstructured":"Gray V, Chen W, Tan RJY et al (2024) Hyperglycemia-triggered lipid peroxidation destabilizes STAT4 and impairs anti-viral Th1 responses in type 2 diabetes. Cell Metab 36(12):2511-2527.e2517","journal-title":"Cell Metab"},{"issue":"3","key":"13594_CR97","volume":"73","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Allela OQB, Kareem RA et al (2025) Immune cell dysfunction: a critical player in development of diabetes complications. Curr Res Transl Med 73(3):103510","journal-title":"Curr Res Transl Med"},{"issue":"10","key":"13594_CR98","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/eji.202249839","volume":"52","author":"S Panda","year":"2022","unstructured":"Panda S, Seelan DM, Faisal S et al (2022) Chronic hyperglycemia drives alterations in macrophage effector function in pulmonary tuberculosis. Eur J Immunol 52(10):1595\u20131609","journal-title":"Eur J Immunol"},{"issue":"1","key":"13594_CR99","volume":"18","author":"P Zhang","year":"2021","unstructured":"Zhang P, Yang CL, Du T et al (2021) Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity. J Neuroinflamm 18(1):244","journal-title":"J Neuroinflamm"},{"issue":"2","key":"13594_CR100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280916","volume":"18","author":"E Pitmon","year":"2023","unstructured":"Pitmon E, Meehan EV, Ahmadi E et al (2023) High glucose promotes regulatory T cell differentiation. PLoS ONE 18(2):e0280916","journal-title":"PLoS ONE"},{"issue":"1","key":"13594_CR101","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2337\/db17-1218","volume":"68","author":"YH Lee","year":"2019","unstructured":"Lee YH, Kim SR, Han DH et al (2019) Senescent T cells predict the development of hyperglycemia in humans. Diabetes 68(1):156\u2013162","journal-title":"Diabetes"},{"issue":"1","key":"13594_CR102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cns.13569","volume":"27","author":"X Huang","year":"2021","unstructured":"Huang X, Hussain B, Chang J (2021) Peripheral inflammation and blood\u2013brain barrier disruption: effects and mechanisms. CNS Neurosci Ther 27(1):36\u201347","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"13594_CR103","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s12035-018-1195-5","volume":"56","author":"S Rom","year":"2019","unstructured":"Rom S, Zuluaga-Ramirez V, Gajghate S et al (2019) Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models. Mol Neurobiol 56(3):1883\u20131896","journal-title":"Mol Neurobiol"},{"issue":"4","key":"13594_CR104","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11154-008-9104-2","volume":"9","author":"C Figueroa-Romero","year":"2008","unstructured":"Figueroa-Romero C, Sadidi M, Feldman EL (2008) Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord 9(4):301\u2013314","journal-title":"Rev Endocr Metab Disord"},{"issue":"43","key":"13594_CR105","doi-asserted-by":"crossref","first-page":"10258","DOI":"10.1523\/JNEUROSCI.2085-17.2017","volume":"37","author":"JA Lindborg","year":"2017","unstructured":"Lindborg JA, Mack M, Zigmond RE (2017) Neutrophils are critical for myelin removal in a peripheral nerve injury model of Wallerian degeneration. J Neurosci 37(43):10258\u201310277","journal-title":"J Neurosci"},{"issue":"12","key":"13594_CR106","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/glia.22570","volume":"61","author":"I Dey","year":"2013","unstructured":"Dey I, Midha N, Singh G et al (2013) Diabetic Schwann cells suffer from nerve growth factor and neurotrophin-3 underproduction and poor associability with axons. Glia 61(12):1990\u20131999","journal-title":"Glia"},{"issue":"2","key":"13594_CR107","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.clinph.2004.08.003","volume":"116","author":"S Misawa","year":"2005","unstructured":"Misawa S, Kuwabara S, Ogawara K et al (2005) Strength-duration properties and glycemic control in human diabetic motor nerves. Clin Neurophysiol 116(2):254\u2013258","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"13594_CR108","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.clinph.2004.06.008","volume":"115","author":"S Misawa","year":"2004","unstructured":"Misawa S, Kuwabara S, Ogawara K et al (2004) Hyperglycemia alters refractory periods in human diabetic neuropathy. Clin Neurophysiol 115(11):2525\u20132529","journal-title":"Clin Neurophysiol"},{"key":"13594_CR109","volume":"961","author":"F Li","year":"2023","unstructured":"Li F, Qian LL, Wu LD et al (2023) Glucose fluctuations aggravated the late sodium current induced ventricular arrhythmias via the activation of ROS\/CaMKII pathway. Eur J Pharmacol 961:176167","journal-title":"Eur J Pharmacol"},{"key":"13594_CR110","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.994585","volume":"16","author":"S Bigsby","year":"2022","unstructured":"Bigsby S, Neapetung J, Campanucci VA (2022) Voltage-gated sodium channels in diabetic sensory neuropathy: function, modulation, and therapeutic potential. Front Cell Neurosci 16:994585","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"13594_CR111","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2119\/molmed.2015.00063","volume":"21","author":"AM Tan","year":"2015","unstructured":"Tan AM, Samad OA, Dib-Hajj SD et al (2015) Virus-mediated knockdown of Nav1.3 in dorsal root ganglia of STZ-induced diabetic rats alleviates tactile allodynia. Mol Med 21(1):544\u2013552","journal-title":"Mol Med"},{"issue":"1","key":"13594_CR112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00424-015-1735-z","volume":"468","author":"M Schink","year":"2016","unstructured":"Schink M, Leipold E, Schirmeyer J et al (2016) Reactive species modify NaV1.8 channels and affect action potentials in murine dorsal root ganglion neurons. Pflugers Arch Eur J Physiol 468(1):99\u2013110","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"13594_CR113","first-page":"16","volume":"7","author":"W Wang","year":"2011","unstructured":"Wang W, Gu J, Li YQ et al (2011) Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? Mol Pain 7:16","journal-title":"Mol Pain"},{"issue":"1","key":"13594_CR114","volume":"8","author":"L Chen","year":"2018","unstructured":"Chen L, Huang J, Zhao P et al (2018) Conditional knockout of Na(V)1.6 in adult mice ameliorates neuropathic pain. Sci Rep 8(1):3845","journal-title":"Sci Rep"},{"key":"13594_CR115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2019.03.025","volume":"401","author":"T De Campos Lima","year":"2019","unstructured":"De Campos Lima T, Santos DO, Lemes JBP et al (2019) Hyperglycemia induces mechanical hyperalgesia and depolarization of the resting membrane potential of primary nociceptive neurons: role of ATP-sensitive potassium channels. J Neurol Sci 401:55\u201361","journal-title":"J Neurol Sci"},{"issue":"12","key":"13594_CR116","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.2337\/dbi15-0006","volume":"64","author":"SM Todorovic","year":"2015","unstructured":"Todorovic SM (2015) Is diabetic nerve pain caused by dysregulated ion channels in sensory neurons? Diabetes 64(12):3987\u20133989","journal-title":"Diabetes"},{"issue":"33","key":"13594_CR117","first-page":"2583","volume":"7","author":"Y Wu","year":"2012","unstructured":"Wu Y, Xue B, Li X et al (2012) Puerarin prevents high glucose-induced apoptosis of Schwann cells by inhibiting oxidative stress. Neural Regen Res 7(33):2583\u20132591","journal-title":"Neural Regen Res"},{"issue":"17","key":"13594_CR118","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204049119","volume":"119","author":"A Belavgeni","year":"2022","unstructured":"Belavgeni A, Maremonti F, Stadtm\u00fcller M et al (2022) Schwann cell necroptosis in diabetic neuropathy. Proc Natl Acad Sci USA 119(17):e2204049119","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"13594_CR119","volume":"119","author":"J Guo","year":"2022","unstructured":"Guo J, Guo Z, Huang Y et al (2022) Blockage of MLKL prevents myelin damage in experimental diabetic neuropathy. Proc Natl Acad Sci USA 119(14):e2121552119","journal-title":"Proc Natl Acad Sci USA"},{"key":"13594_CR120","volume":"248","author":"YP Liu","year":"2020","unstructured":"Liu YP, Shao SJ, Guo HD (2020) Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy. Life Sci 248:117459","journal-title":"Life Sci"},{"issue":"10","key":"13594_CR121","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s11064-024-04200-1","volume":"49","author":"T Jin","year":"2024","unstructured":"Jin T, Wang Z, Fan F et al (2024) HDAC1 promotes mitochondrial pathway apoptosis and inhibits the endoplasmic reticulum stress response in high glucose-treated Schwann cells via decreased U4 spliceosomal RNA. Neurochem Res 49(10):2699\u20132724","journal-title":"Neurochem Res"},{"issue":"2","key":"13594_CR122","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000354444","volume":"32","author":"YB Wu","year":"2013","unstructured":"Wu YB, Li HQ, Ren MS et al (2013) CHOP\/ORP150 ratio in endoplasmic reticulum stress: a new mechanism for diabetic peripheral neuropathy. Cell Physiol Biochem 32(2):367\u2013379","journal-title":"Cell Physiol Biochem"},{"key":"13594_CR123","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-025-02603-2","author":"N Lai","year":"2025","unstructured":"Lai N (2025) Mechanism and treatment progress of endoplasmic reticulum stress pathway in diabetic neuropathy. Acta Diabetologica. https:\/\/doi.org\/10.1007\/s00592-025-02603-2","journal-title":"Acta Diabetologica"},{"issue":"12","key":"13594_CR124","first-page":"1190","volume":"39","author":"T Hao","year":"2023","unstructured":"Hao T, Cao T, Ji P et al (2023) Research advances on the role of Schwann cells in diabetic peripheral neuropathy. Zhonghua shao shang yu chuang mian xiu fu za zhi 39(12):1190\u20131194","journal-title":"Zhonghua shao shang yu chuang mian xiu fu za zhi"},{"issue":"14","key":"13594_CR125","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/glia.20766","volume":"56","author":"R Martini","year":"2008","unstructured":"Martini R, Fischer S, L\u00f3pez-Vales R et al (2008) Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 56(14):1566\u20131577","journal-title":"Glia"},{"issue":"8","key":"13594_CR126","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1523\/JNEUROSCI.22-08-03052.2002","volume":"22","author":"S Shamash","year":"2002","unstructured":"Shamash S, Reichert F, Rotshenker S (2002) The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci 22(8):3052\u20133060","journal-title":"J Neurosci"},{"key":"13594_CR127","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2024.03.006","volume":"169","author":"S Jiang","year":"2024","unstructured":"Jiang S, Li W, Song M et al (2024) CXCL1-CXCR2 axis mediates inflammatory response after sciatic nerve injury by regulating macrophage infiltration. Mol Immunol 169:50\u201365","journal-title":"Mol Immunol"},{"issue":"3","key":"13594_CR128","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbrc.2006.09.108","volume":"350","author":"H Lee","year":"2006","unstructured":"Lee H, Jo EK, Choi SY et al (2006) Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem Biophys Res Commun 350(3):742\u2013747","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"13594_CR129","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0006-8993(92)90097-S","volume":"575","author":"NA Calcutt","year":"1992","unstructured":"Calcutt NA, Muir D, Powell HC et al (1992) Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats. Brain Res 575(2):320\u2013324","journal-title":"Brain Res"},{"issue":"6","key":"13594_CR130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4093\/dmj.2023.0018","volume":"47","author":"HN Jang","year":"2023","unstructured":"Jang HN, Oh TJ (2023) Pharmacological and nonpharmacological treatments for painful diabetic peripheral neuropathy. Diabetes Metab J 47(6):743\u2013756","journal-title":"Diabetes Metab J"},{"issue":"21","key":"13594_CR131","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","volume":"280","author":"M Backonja","year":"1998","unstructured":"Backonja M, Beydoun A, Edwards KR et al (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280(21):1831\u20131836","journal-title":"JAMA"},{"issue":"1","key":"13594_CR132","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13300-018-0550-x","volume":"10","author":"S Azmi","year":"2019","unstructured":"Azmi S, Elhadd KT, Nelson A et al (2019) Pregabalin in the management of painful diabetic neuropathy: a narrative review. Diabetes Ther 10(1):35\u201356","journal-title":"Diabetes Ther"},{"issue":"3","key":"13594_CR133","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","volume":"110","author":"J Rosenstock","year":"2004","unstructured":"Rosenstock J, Tuchman M, Lamoreaux L et al (2004) Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110(3):628\u2013638","journal-title":"Pain"},{"issue":"3","key":"13594_CR134","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1753-0407.12585","volume":"10","author":"Y Mu","year":"2018","unstructured":"Mu Y, Liu X, Li Q et al (2018) Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: a randomized placebo-controlled trial. J Diabetes 10(3):256\u2013265","journal-title":"J Diabetes"},{"issue":"5","key":"13594_CR135","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/jdi.13013","volume":"10","author":"M Baba","year":"2019","unstructured":"Baba M, Matsui N, Kuroha M et al (2019) Mirogabalin for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase\u00a0III study in Asian patients. J Diabetes Investig 10(5):1299\u20131306","journal-title":"J Diabetes Investig"},{"issue":"4","key":"13594_CR136","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s40122-024-00617-2","volume":"13","author":"X Guo","year":"2024","unstructured":"Guo X, Yu Y, Zhang Y et al (2024) A phase 3, multicenter, randomized, double-blind, placebo-controlled 14-week study of Mirogabalin in Chinese patients with diabetic peripheral neuropathic pain. Pain Ther 13(4):937\u2013952","journal-title":"Pain Ther"},{"key":"13594_CR137","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.actbio.2017.02.004","volume":"53","author":"K Suzuki","year":"2017","unstructured":"Suzuki K, Tanaka H, Ebara M et al (2017) Electrospun nanofiber sheets incorporating methylcobalamin promote nerve regeneration and functional recovery in a rat sciatic nerve crush injury model. Acta Biomater 53:250\u2013259","journal-title":"Acta Biomater"},{"issue":"22","key":"13594_CR138","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4103\/1673-5374.145379","volume":"9","author":"L Gan","year":"2014","unstructured":"Gan L, Qian M, Shi K et al (2014) Restorative effect and mechanism of mecobalamin on sciatic nerve crush injury in mice. Neural Regen Res 9(22):1979\u20131984","journal-title":"Neural Regen Res"},{"key":"13594_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020395","author":"T Didangelos","year":"2021","unstructured":"Didangelos T, Karlafti E, Kotzakioulafi E et al (2021) Vitamin B12 supplementation in diabetic neuropathy: a 1-year, randomized, double-blind, placebo-controlled trial. Nutrients. https:\/\/doi.org\/10.3390\/nu13020395","journal-title":"Nutrients"},{"issue":"4","key":"13594_CR140","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2362.2010.02430.x","volume":"41","author":"H Mizukami","year":"2011","unstructured":"Mizukami H, Ogasawara S, Yamagishi S et al (2011) Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats. Eur J Clin Invest 41(4):442\u2013450","journal-title":"Eur J Clin Invest"},{"key":"13594_CR141","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.lfs.2016.07.019","volume":"161","author":"H Yao","year":"2016","unstructured":"Yao H, Feng J, Zheng Q et al (2016) The effects of gliclazide, methylcobalamin, and gliclazide+methylcobalamin combination therapy on diabetic peripheral neuropathy in rats. Life Sci 161:60\u201368","journal-title":"Life Sci"},{"issue":"1","key":"13594_CR142","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/13880209.2024.2422084","volume":"62","author":"Q Wang","year":"2024","unstructured":"Wang Q, Xie H, Wang Z et al (2024) Comparative efficacy and safety of Chinese patent medicines as an adjunctive therapy for diabetic peripheral neuropathy: systematic review and network meta-analysis of randomized controlled trials. Pharm Biol 62(1):833\u2013852","journal-title":"Pharm Biol"},{"issue":"12","key":"13594_CR143","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1089\/acm.2020.0068","volume":"26","author":"R Sawangjit","year":"2020","unstructured":"Sawangjit R, Thongphui S, Chaichompu W et al (2020) Efficacy and safety of mecobalamin on peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials. J Altern Complement Med 26(12):1117\u20131129","journal-title":"J Altern Complement Med"},{"issue":"44","key":"13594_CR144","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013020","volume":"97","author":"DQ Jiang","year":"2018","unstructured":"Jiang DQ, Zhao SH, Li MX et al (2018) Prostaglandin E1 plus methylcobalamin combination therapy versus prostaglandin E1 monotherapy for patients with diabetic peripheral neuropathy: a meta-analysis of randomized controlled trials. Medicine 97(44):e13020","journal-title":"Medicine"},{"issue":"3","key":"13594_CR145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12020-014-0181-6","volume":"46","author":"H Deng","year":"2014","unstructured":"Deng H, Yin J, Zhang J et al (2014) Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy. Endocrine 46(3):445\u2013454","journal-title":"Endocrine"},{"issue":"2","key":"13594_CR146","first-page":"113","volume":"126","author":"F Mo","year":"2018","unstructured":"Mo F, Hu G, Liu W et al (2018) Prostaglandin E1 protects the peripheral nerve in diabetics through preventing vascular permeability changes. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc 126(2):113\u2013122","journal-title":"Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc"},{"issue":"1","key":"13594_CR147","volume":"12","author":"CS Wu","year":"2023","unstructured":"Wu CS, Huang YJ, Ko YC et al (2023) Efficacy and safety of duloxetine in painful diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials. Syst Rev 12(1):53","journal-title":"Syst Rev"},{"issue":"8","key":"13594_CR148","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/pm\/pnz027","volume":"20","author":"SI Konno","year":"2019","unstructured":"Konno SI, Alev L, Oda N et al (2019) An open-label, 52-week, phase III trial of duloxetine in Japanese patients with chronic low back pain. Pain Med 20(8):1479\u20131488","journal-title":"Pain Med"},{"issue":"2","key":"13594_CR149","volume":"38","author":"GL Ran","year":"2024","unstructured":"Ran GL, Li YP, Lu LC et al (2024) Disease-modifying therapies for diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Complicat 38(2):108691","journal-title":"J Diabetes Complicat"},{"issue":"3","key":"13594_CR150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nm834","volume":"9","author":"HP Hammes","year":"2003","unstructured":"Hammes HP, Du X, Edelstein D et al (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9(3):294\u2013299","journal-title":"Nat Med"},{"issue":"10","key":"13594_CR151","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1055\/s-2008-1065351","volume":"116","author":"H Stracke","year":"2008","unstructured":"Stracke H, Gaus W, Achenbach U et al (2008) Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes 116(10):600\u2013605","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"13594_CR152","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109063","volume":"186","author":"D Ziegler","year":"2022","unstructured":"Ziegler D, Tesfaye S, Spallone V et al (2022) Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: international expert consensus recommendations. Diabetes Res Clin Pract 186:109063","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"13594_CR153","first-page":"11","volume":"43","author":"Y Han","year":"2018","unstructured":"Han Y, Wang M, Shen J et al (2018) Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy. Minerva Endocrinol 43(1):11\u201318","journal-title":"Minerva Endocrinol"},{"issue":"7","key":"13594_CR154","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s11064-022-03598-w","volume":"47","author":"H Khan","year":"2022","unstructured":"Khan H, Singh TG, Dahiya RS et al (2022) \u03b1-Lipoic acid, an organosulfur biomolecule a novel therapeutic agent for neurodegenerative disorders: an mechanistic perspective. Neurochem Res 47(7):1853\u20131864","journal-title":"Neurochem Res"},{"issue":"4","key":"13594_CR155","first-page":"2774","volume":"13","author":"C Tang","year":"2021","unstructured":"Tang C, Han R, Wu J et al (2021) Effects of baicalin capsules combined with \u03b1-lipoic acid on nerve conduction velocity, oxidative stress and inflammatory injury in patients with diabetic peripheral neuropathy. Am J Transl Res 13(4):2774\u20132783","journal-title":"Am J Transl Res"},{"issue":"27","key":"13594_CR156","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011390","volume":"97","author":"DQ Jiang","year":"2018","unstructured":"Jiang DQ, Xu LC, Jiang LL et al (2018) Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: a meta-analysis. Medicine (Baltimore) 97(27):e11390","journal-title":"Medicine (Baltimore)"},{"key":"13594_CR157","volume":"741","author":"HY Peng","year":"2021","unstructured":"Peng HY, Gong YY (2021) Analysis of the effect of probucol-mecobalamin tablets combination on oxidative stress in patients with diabetic peripheral neuropathy. Neurosci Lett 741:135484","journal-title":"Neurosci Lett"},{"issue":"7","key":"13594_CR158","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2337\/dc05-2370","volume":"29","author":"N Hotta","year":"2006","unstructured":"Hotta N, Akanuma Y, Kawamori R et al (2006) Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care 29(7):1538\u20131544","journal-title":"Diabetes Care"},{"issue":"2","key":"13594_CR159","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/1673-5374.177745","volume":"11","author":"QR Li","year":"2016","unstructured":"Li QR, Wang Z, Zhou W et al (2016) Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway. Neural Regen Res 11(2):345\u2013351","journal-title":"Neural Regen Res"},{"issue":"2","key":"13594_CR160","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/jdi.12890","volume":"10","author":"K Sekiguchi","year":"2019","unstructured":"Sekiguchi K, Kohara N, Baba M et al (2019) Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: a randomized double-blind placebo-controlled study in Japan. J Diabetes Investig 10(2):466\u2013474","journal-title":"J Diabetes Investig"},{"key":"13594_CR161","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.2147\/DDDT.S168878","volume":"12","author":"X Wang","year":"2018","unstructured":"Wang X, Lin H, Xu S et al (2018) Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy. Drug Des Dev Ther 12:2827\u20132840","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"13594_CR162","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jns.12138","volume":"20","author":"M Polydefkis","year":"2015","unstructured":"Polydefkis M, Arezzo J, Nash M et al (2015) Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy. J Peripher Nerv Syst 20(4):363\u2013371","journal-title":"J Peripher Nerv Syst"},{"issue":"11","key":"13594_CR163","doi-asserted-by":"crossref","first-page":"dmm040584","DOI":"10.1242\/dmm.040584","volume":"12","author":"S Iyer","year":"2019","unstructured":"Iyer S, Sam FS, Diprimio N et al (2019) Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. Dis Models Mech 12(11):dmm040584","journal-title":"Dis Models Mech"},{"issue":"5","key":"13594_CR164","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01781","volume":"5","author":"S Samaddar","year":"2019","unstructured":"Samaddar S, Koneri R (2019) Polyphenols of marine red macroalga Symphyocladia latiuscula ameliorate diabetic peripheral neuropathy in experimental animals. Heliyon 5(5):e01781","journal-title":"Heliyon"},{"issue":"8","key":"13594_CR165","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc09-0545","volume":"32","author":"D Ziegler","year":"2009","unstructured":"Ziegler D, Movsesyan L, Mankovsky B et al (2009) Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients. Diabetes Care 32(8):1479\u20131484","journal-title":"Diabetes Care"},{"issue":"1","key":"13594_CR166","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01680-0","volume":"11","author":"C De Gregorio","year":"2020","unstructured":"De Gregorio C, Contador D, D\u00edaz D et al (2020) Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db\/db mice. Stem Cell Res Ther 11(1):168","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"13594_CR167","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1224-3","volume":"15","author":"AF Evangelista","year":"2018","unstructured":"Evangelista AF, Vannier-Santos MA, De Assis Silva GS et al (2018) Bone marrow-derived mesenchymal stem\/stromal cells reverse the sensorial diabetic neuropathy via modulation of spinal neuroinflammatory cascades. J Neuroinflamm 15(1):189","journal-title":"J Neuroinflamm"},{"key":"13594_CR168","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2024.12.035","volume":"566","author":"SD Alizadeh","year":"2025","unstructured":"Alizadeh SD, Hassan Zadeh Tabatabaei MS, Rezaei Zadeh Rukerd M et al (2025) The safety and efficacy of stem cell therapy for diabetic peripheral neuropathy in animal studies: a systematic review and meta-analysis. Neuroscience 566:49\u201359","journal-title":"Neuroscience"},{"issue":"5","key":"13594_CR169","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/19322968221099542","volume":"17","author":"DG Armstrong","year":"2023","unstructured":"Armstrong DG, Grunberger G (2023) Stimulating results signal a new treatment option for people living with painful diabetic neuropathy. J Diabetes Sci Technol 17(5):1387\u20131391","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"13594_CR170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2010.03.021","volume":"89","author":"DM Jin","year":"2010","unstructured":"Jin DM, Xu Y, Geng DF et al (2010) Effect of transcutaneous electrical nerve stimulation on symptomatic diabetic peripheral neuropathy: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 89(1):10\u201315","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"13594_CR171","first-page":"E1163","volume":"25","author":"EJ Wang","year":"2022","unstructured":"Wang EJ, Berninger LE, Komargodski O et al (2022) Painful diabetic neuropathy\u2014spinal cord stimulation, peripheral nerve stimulation, transcutaneous electrical nerve stimulation, and scrambler therapy: a narrative review. Pain Physician 25(8):E1163-e1173","journal-title":"Pain Physician"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13594-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13594-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13594-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:04:08Z","timestamp":1773785048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13594-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":171,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["13594"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13594-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"105"}}